Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation.

Authors :: Iafusco D
Zanfardino A
Piscopo A
Casaburo F
De Nigris A
Alfiero S
Russo G
Arenella M
Russo MC
Barbetti F
Source :: Diabetologia [Diabetologia] 2021 Jul; Vol. 64 (7), pp. 1703-1706. Date of Electronic Publication: 2021 May 14.
Publication Year :: 2021

Subjects :: Amino Acid Substitution
Arginine genetics
Celiac Disease diet therapy
Celiac Disease drug therapy
Child, Preschool
Combined Modality Therapy
Cysteine genetics
Diabetes Mellitus diet therapy
Diabetes Mellitus genetics
Diet, Gluten-Free
Female
Humans
Italy
Mutation, Missense
Potassium Channels, Inwardly Rectifying genetics
Treatment Failure
Celiac Disease complications
Diabetes Mellitus drug therapy
Glyburide therapeutic use

Full Text Access

Tools